← All indications
Urolithiasis
Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.
Subtype terms (3)
More specific conditions that are subtypes of Urolithiasis in the MeSH hierarchy.
- Nephrolithiasis
60 drugs (42 approved, 18 experimental)
- Ureterolithiasis
7 drugs approved
- Urinary Calculi
17 drugs (16 approved, 1 experimental)
Drugs by status
Phase 4 trials (13)
Phase 2 trials (2)
Organizations
Organization Involved with Phase 4 Indications (11)
- Dawnrays Pharmaceutical (Holdings) Limited
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- Mansoura University
- Pamukkale University
- Pontificia Universidad Catolica de Chile
- Zhongshan Medical University
- New York Presbyterian Hospital
- George Washington University
- Yeshiva University
- Shanghai Xuhui District Central Hospital
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (6)
Organization Involved with Other Experimental Indications (13)
- Otsuka
- United States Navy
- Tamil Nadu Dr.M.G.R.Medical University
- Harvard University
- Emory University
- Guangzhou Medical University
- University of California, San Diego
- University of Colorado, Denver
- The Tamilnadu Dr. MGR. Medical University
- University of Alabama, Birmingham
- University of Colorado
- Genesis HealthCare
- Devicare S.L.